Table 3.

Prevalence of actionability using CPIC guidelines and FDA labeling

Medication data available (N = 600)	CPIC	FDA
Genetic resultsa
Actionable result (i.e., may be actionable now or in the future)	595	523
No actionable result	5	77
Current prescriptions affected by PGx results
Current prescription for an affected drugb	277	168
Recommendation: modify usec	97	27
Recommendation: regular use	180	141
No current prescription for an affected drug	323	432

CPIC, Clinical Pharmacogenetics Implementation Consortium; FDA, US Food and Drug Administration; PGx, pharmacogenomics.

^aMore patients possessed an actionable results per CPIC than the FDA (P < 0.0001).

^bMore patients possessed a prescription for drug affected by PGx results per CPIC than the FDA (P < 0.0001).

^cMore patients possessed an actionable result for a medication they were currently prescribed per CPIC than the FDA (P < 0.0001).